Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heparinization vs Salinization of the Peripheral Venous Catheter
NCT05209841Terminated
- Sponsor
- Consorci Sanitari de l'Alt Penedès i Garraf
- Start
- Apr 2022
- Primary completion
- Jul 2025
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of heparin in Catheter-related complications (2 arms), sponsored by Consorci Sanitari de l'Alt Penedès i Garraf. Primary endpoint: Percentage of obstructed catheters at 10 days. Started Apr 2022; status: terminated.
02
Drugs
heparin
03
Conditions
Catheter-related complications
Beyond the preview
Go deeper on NCT05209841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05209841.